Graves' disease is an immune system condition characterized by excessive thyroid hormone production (hyperthyroidism). Graves' disease is a common cause of hyperthyroidism, though a variety of conditions can cause it. Graves' disease has a wide range of signs and symptoms because thyroid hormones affect many different body systems. Graves' disease can affect anyone, however it is more common in women and those under the age of 40.
ask for a sample copy of the report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-graves-disease-overactive-thyroid-market
Data Bridge Market Research analyses that the Graves' disease (overactive thyroid) market was valued at USD 351.55 million in 2021 and is expected to reach USD 507.65 million by 2029, registering a CAGR of 4.70% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Graves' disease (overactive thyroid), sometimes known as Basedow's disease, is an autoimmune condition that leads to hyperthyroidism. It occurs when the body's immune cells attack the thyroid, causing excessive thyroid hormone production. Graves' disease treatment aims to inhibit thyroid hormone production and block the hormones' effects on the body. Beta-blockers including propranolol and metoprolol are frequently used as first-line treatments. These medications help to keep your heart rate in check and safeguard it until other hyperthyroidism treatments take effect. Antithyroid drugs like methimazole (Tapazole) and propylthiouracil stop the thyroid gland from producing thyroid hormone. Radioiodine therapy entails taking a single dose of radioactive iodine in the form of a pill or a liquid. Radiation kills thyroid gland cells over a period of two to three months.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Graves' disease (overactive thyroid) market growth.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the Graves' disease (overactive thyroid) market growth during the forecast period.
Top key players operating in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Allergan (Ireland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Hikma Pharmaceuticals PLC (U.K.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH. (Germany), Dr. Reddy's Laboratories Ltd. (India), Gilead Sciences, Inc. (U.S.), Amgen Inc. (U.S.), Eli Lilly and Company (U.S.), AbbVie Inc. (U.S.), Lupin (India), Allergan (Ireland)
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com